Centessa Pharmaceuticals Ownership | Who Owns Centessa Pharmaceuticals?
Centessa Pharmaceuticals Ownership Summary
Centessa Pharmaceuticals is owned by 93.39% institutional investors, 1.36% insiders, and 5.25% retail investors. Medicxi ventures management (jersey) is the largest institutional shareholder, holding 19.99% of CNTA shares. T. Rowe Price Health Sciences is the top mutual fund, with 2.29% of its assets in Centessa Pharmaceuticals shares.
CNTA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Centessa Pharmaceuticals | 93.39% | 1.36% | 5.25% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 19.96M | 19.99% | $180.27M |
| General atlantic | 9.68M | 9.69% | $87.43M |
| Ecor1 capital | 5.71M | 5.72% | $51.60M |
| First light asset management | 4.78M | 4.79% | $43.17M |
| Perceptive advisors | 3.93M | 3.94% | $35.52M |
| Vida ventures advisors | 3.93M | 3.94% | $35.50M |
| Price t rowe associates inc /md/ | 3.53M | 3.53% | $31.88M |
| Adage capital partners gp | 3.13M | 3.13% | $28.22M |
| Tcg crossover management | 2.89M | 2.89% | $26.10M |
| Fmr | 2.79M | 2.79% | $25.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 19.96M | 53.77% | $180.27M |
| Vida ventures advisors | 3.93M | 38.83% | $35.50M |
| First light asset management | 4.78M | 3.78% | $43.17M |
| Octagon capital advisors lp | 2.35M | 3.33% | $21.18M |
| General atlantic | 9.68M | 2.75% | $87.43M |
| Tcg crossover management | 2.89M | 2.72% | $26.10M |
| 5am venture management | 1.25M | 2.51% | $11.24M |
| Exome asset management | 274.90K | 2.21% | $2.48M |
| Ecor1 capital | 5.71M | 1.58% | $51.60M |
| Affinity asset advisors | 1.14M | 1.18% | $10.26M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| First light asset management | 4.78M | 3.78% | 1.78M |
| Farallon capital management | 2.00M | 0.09% | 1.63M |
| Cormorant asset management, lp | 1.61M | 0.84% | 1.05M |
| Driehaus capital management | 2.09M | 0.18% | 988.00K |
| Adage capital partners gp | 3.13M | 0.05% | 875.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 1.76M | 0.04% | -495.71K |
| Millennium management | 49.48K | 0.00% | -237.91K |
| Ensign peak advisors | - | - | -125.16K |
| Landscape capital management | - | - | -90.24K |
| Exoduspoint capital management, lp | - | - | -87.21K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| T. rowe price investment management | 833.99K | 0.00% | 833.99K | $7.53M |
| Baker bros. advisors lp | 549.21K | 0.06% | 549.21K | $4.96M |
| Nantahala capital management | 450.00K | 0.24% | 450.00K | $4.06M |
| Dafna capital management | 122.88K | 0.27% | 122.88K | $1.11M |
| Monashee investment management | 103.19K | 0.12% | 103.19K | $931.82K |
Sold Out
| Holder | Change |
|---|---|
| Spire wealth management | -70.00 |
| Advisor group | -407.00 |
| Advisors preferred | -1.82K |
| State of tennessee, treasury department | -5.80K |
| Quarry lp | -9.61K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 106 | 29.27% | 108,573,103 | 25.51% | 93 | 1.50% | 76 | 72.73% | 16 | -15.79% |
| Jun 30, 2024 | 81 | 14.08% | 86,506,233 | 16.28% | 86 | 1.45% | 44 | -6.38% | 18 | 260.00% |
| Mar 31, 2024 | 71 | 16.39% | 74,395,273 | 4.37% | 77 | 1.42% | 47 | 56.67% | 5 | -54.55% |
| Dec 31, 2023 | 61 | 22.00% | 71,280,100 | -1.79% | 73 | 1.27% | 30 | 36.36% | 11 | 10.00% |
| Sep 30, 2023 | 50 | 8.70% | 72,578,636 | 3.18% | 76 | 1.39% | 22 | 15.79% | 10 | 42.86% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 2.95M | 2.29% | 836.05K |
| Fidelity Select Biotechnology | 2.92M | 2.27% | 129.30K |
| Franklin Biotechnology Discv A(acc)USD | 1.18M | 0.92% | 467.60K |
| American Century U.S. Small Cap Growth | 1.00M | 0.78% | 190.43K |
| American Century Small Cap Growth Inv | 1.00M | 0.78% | 190.43K |
| T. Rowe Price US Small-Cap Core Equity | 893.71K | 0.70% | 893.71K |
| T. Rowe Price Small-Cap Stock | 893.71K | 0.70% | 213.89K |
| T. Rowe Price Small-Cap Value | 694.10K | 0.54% | -82.05K |
| Franklin Biotechnology Discovery A | 678.97K | 0.53% | 287.50K |
| T. Rowe Price New Horizons | 645.19K | 0.50% | -2.03K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 13, 2024 | SAHA SAURABH | Chief Executive Officer | Sell | $585.42K |
| Oct 25, 2024 | Weinhoff Gregory M | Chief Business Officer | Sell | $180.63K |
| Oct 23, 2024 | SAHA SAURABH | Chief Executive Officer | Sell | $39.70K |
| Oct 21, 2024 | SAHA SAURABH | Chief Executive Officer | Sell | $350.86K |
| Oct 22, 2024 | SAHA SAURABH | Chief Executive Officer | Sell | $473.17K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 5 |
| 2024 Q3 | - | 11 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 3 |
| 2023 Q4 | - | - |
CNTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools